Effects of erythropoietin on myocardial vascular endothelial growth factor expression and cardiac dysfunction in diabetic rats

LU Jing,DAI Qi-ming,ZHANG Shu-feng,CAO Lei,LIU Nai-feng
2012-01-01
Abstract:AIM To investigate the effects of erythropoietin(EPO) on ventricular remodeling,cardiac function and the expressions of vascular endothelial growth factor(VEGF) and EPO - receptor(EPOR) in diabetic rats.METHODS Thirty-six male SD rats were randomly divided into control group,diabetic group and EPO-treated group(n =12 for each).The diabetic model was induced by streptozotocin(STZ).In the EPO-treated group,diabetic rats were treated with 1 000 IU ? kg~(-1) EPO by subcutaneous injection once per week for twelve weeks.At the seventh day after the last administration,echocardiography was conducted.Blood samples from tail vein were collected for blood glucose and red blood cell numbers measurements.Counting of peripheral blood endothelial progenitor cells(EPCs) was analyzed by flow cytometry.Collecting myocardial tissues, quantitative real-time PCR(RT-PCR) was used to detect the mRNA level of VEGF and EPOR,and Western blot was used to detect the protein expression of VEGF and EPOR.CD31 level in the myocardium was determined by immunohistochemistry in terms of capillary density.RESULTS Compared with the control group, EPCs numbers and the capillary density of rats reduced significantly in the diabetic group.The mRNA levels and the protein expressions of VEGF and EPOR also decreased(P < 0.01).And LVDd and LVDs increased, ejection fraction(EF) decreased significantly in STZ induced diabetic rats.Rats receiving the EPO injection showed a significant increase in circulating EPCs compared with the diabetic group rats(P < 0.01).EPO treatment significantly increased the mRNA levels and the protein expressions of VEGF and EPOR,and the capillary density compared with diabetic rats(P < 0.01).LVDd and LVDs significantly decreased and EF increased in the EPO - treated group compared with the diabetic group(P < 0.05).CONCLUSION EPO treatment can increase EPCs,the protein and mRNA expression levels of VEGF and EPOR,and improve revascularization.These might be one of the mechanisms of EPO protecting cardiac function in diabetic rats.
What problem does this paper attempt to address?